Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Landos Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +5 vs. Q3 2021
- Shares held
- 24.9M
- +2.27M (+10.0%) vs. Q3 2021
- Total value
- $119.8M
- −$211.3M (−63.8%) vs. Q3 2021
- New holders
- 11
- 12 more added
- Sold out
- 6
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 14,869,915 | $71.4M | 1.10% | 00.0% | Unchanged |
| RTW Investments, LP | 4,275,722 | $20.5M | 0.30% | 00.0% | Unchanged |
| OUP Management Co., LLC | 1,827,478 | $8.77M | 3.95% | +1,827,478 | New |
| Logos Global Management LP | 1,375,000 | $6.60M | 0.68% | −30,000−2.1% | Reduced |
| BlackRock Inc. | 470,428 | $2.26M | 0.00% | +236,812+101.4% | Added |
| Vanguard Group Inc | 304,798 | $1.46M | 0.00% | +40.0% | Added |
| JPMorgan Chase & Co | 299,616 | $1.44M | 0.00% | −10,376−3.3% | Reduced |
| OrbiMed Advisors LLC | 283,217 | $1.36M | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 171,100 | $821.0K | 0.00% | +160,200+1,469.7% | Added |
| Morgan Stanley | 153,776 | $738.0K | 0.00% | +152,033+8,722.5% | Added |
| Macquarie Group Ltd | 147,182 | $706.0K | 0.00% | 00.0% | Unchanged |
| Botty Investors LLC | 128,750 | $618.0K | 0.18% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 113,924 | $546.0K | 0.00% | +991+0.9% | Added |
| State Street Corp | 107,596 | $516.0K | 0.00% | +300.0% | Added |
| Walleye Capital LLC | 105,208 | $505.0K | 0.02% | +105,208 | New |
| Two Sigma Investments, LP | 54,778 | $263.0K | 0.00% | +54,778 | New |
| Northern Trust Corp | 46,007 | $221.0K | 0.00% | −673−1.4% | Reduced |
| Walleye Trading LLC | 43,279 | $208.0K | 0.00% | +43,279 | New |
| Bank of America Corp | 31,225 | $150.0K | 0.00% | +29,739+2,001.3% | Added |
| Two Sigma Advisers, LP | 25,700 | $123.0K | 0.00% | +25,700 | New |
| Goldman Sachs Group Inc | 17,568 | $84.0K | 0.00% | +17,568 | New |
| Jump Financial, LLC | 15,200 | $73.0K | 0.00% | +15,200 | New |
| Charles Schwab Investment Management Inc | 13,960 | $68.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,979 | $63.0K | 0.00% | −1,974−13.2% | Reduced |
| STRS Ohio | 11,400 | $54.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 8,151 | $39.0K | 0.00% | +7,532+1,216.8% | Added |
| Acadian Asset Management LLC | 8,274 | $39.0K | 0.00% | +8,274 | New |
| Allworth Financial LP | 5,286 | $25.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,972 | $19.0K | 0.00% | +3,320+509.2% | Added |
| UBS Group AG | 3,805 | $18.0K | 0.00% | +3,805 | New |
| Deutsche Bank AG | 2,843 | $14.0K | 0.00% | +150+5.6% | Added |
| New York State Common Retirement Fund | 2,741 | $13.0K | 0.00% | −15−0.5% | Reduced |
| American International Group, Inc. | 2,487 | $12.0K | 0.00% | −76−3.0% | Reduced |
| Citigroup Inc | 2,448 | $12.0K | 0.00% | +1,900+346.7% | Added |
| California State Teachers Retirement System | 1,566 | $8.00K | 0.00% | −964−38.1% | Reduced |
| Ameritas Investment Partners, Inc. | 515 | $2.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 408 | $2.00K | 0.00% | 00.0% | Unchanged |
| Carroll Financial Associates, Inc. | 408 | $2.00K | 0.00% | +15+3.8% | Added |
| Manchester Capital Management LLC | 406 | $2.00K | 0.00% | +406 | New |
| Wells Fargo & Company | 14 | $0 | 0.00% | +14 | New |
| Woodline Partners LP | 0 | $0 | 0.00% | −212,800−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −18,831−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −18,174−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Cahill Financial Advisors Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |